145 related articles for article (PubMed ID: 27375484)
21. Pharmacokinetics of bambuterol in healthy subjects.
Nyberg L; Rosenborg J; Weibull E; Jönsson S; Kennedy BM; Nilsson M
Br J Clin Pharmacol; 1998 May; 45(5):471-8. PubMed ID: 9643620
[TBL] [Abstract][Full Text] [Related]
22. Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline.
Ewing P; Eirefelt SJ; Andersson P; Blomgren A; Ryrfeldt A; Gerde P
J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):169-80. PubMed ID: 18518793
[TBL] [Abstract][Full Text] [Related]
23. Urinary and blood concentrations of beta2-agonists in trained subjects: comparison between routes of use.
Pichon A; Venisse N; Krupka E; Pérault-Pochat MC; Denjean A
Int J Sports Med; 2006 Mar; 27(3):187-92. PubMed ID: 16541373
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
Lecaillon JB; Kaiser G; Palmisano M; Morgan J; Della Cioppa G
Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
[TBL] [Abstract][Full Text] [Related]
25. Clinical-pharmacokinetic aspects of prolonged effect duration as illustrated by beta2-agonists.
Rosenburg J
Eur J Clin Pharmacol; 2002 Jul; 58(4):S1-21. PubMed ID: 12214578
[TBL] [Abstract][Full Text] [Related]
26. The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects.
Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Clin J Sport Med; 2012 Mar; 22(2):140-5. PubMed ID: 22388343
[TBL] [Abstract][Full Text] [Related]
27. Exercise increases the rate of pulmonary absorption of inhaled terbutaline.
Schmekel B; Borgström L; Wollmer P
Chest; 1992 Mar; 101(3):742-5. PubMed ID: 1541141
[TBL] [Abstract][Full Text] [Related]
28. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
[TBL] [Abstract][Full Text] [Related]
29. Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control.
Ventura R; Segura J; Bergés R; Fitch KD; Morton AR; Berruezo S; Jiménez C
Ther Drug Monit; 2000 Jun; 22(3):277-82. PubMed ID: 10850394
[TBL] [Abstract][Full Text] [Related]
30. Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis.
Deventer K; Pozo OJ; Delbeke FT; Van Eenoo P
Drug Test Anal; 2012 Jun; 4(6):449-54. PubMed ID: 22447497
[TBL] [Abstract][Full Text] [Related]
31. Two-week inhalation of budesonide increases muscle Na,K ATPase content but not endurance in response to terbutaline in men.
Hostrup M; Jessen S; Onslev J; Clausen T; Porsbjerg C
Scand J Med Sci Sports; 2017 Jul; 27(7):684-691. PubMed ID: 27060857
[TBL] [Abstract][Full Text] [Related]
32. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment.
Bergés R; Segura J; Ventura R; Fitch KD; Morton AR; Farré M; Mas M; de La Torre X
Clin Chem; 2000 Sep; 46(9):1365-75. PubMed ID: 10973867
[TBL] [Abstract][Full Text] [Related]
33. Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes.
Hostrup M; Kalsen A; Auchenberg M; Rzeppa S; Hemmersbach P; Bangsbo J; Backer V
Drug Test Anal; 2014 Jun; 6(6):528-32. PubMed ID: 24166762
[TBL] [Abstract][Full Text] [Related]
34. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
Kirby S; Falcoz C; Daniel MJ; Milleri S; Squassante L; Ziviani L; Ventresca GP
Eur J Clin Pharmacol; 2001; 56(11):781-91. PubMed ID: 11294367
[TBL] [Abstract][Full Text] [Related]
35. N,N-dimethyl-2-phenylpropan-1-amine quantification in urine: application to excretion study following single oral dietary supplement dose.
Wójtowicz M; Jarek A; Chajewska K; Kwiatkowska D
Anal Bioanal Chem; 2016 Jul; 408(18):5041-7. PubMed ID: 27178556
[TBL] [Abstract][Full Text] [Related]
36. Effect of inhaled terbutaline on substrate utilization and 300-kcal time trial performance.
Kalsen A; Hostrup M; Karlsson S; Hemmersbach P; Bangsbo J; Backer V
J Appl Physiol (1985); 2014 Nov; 117(10):1180-7. PubMed ID: 25257871
[TBL] [Abstract][Full Text] [Related]
37. Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurised inhaler and a dry powder inhaler.
Mortensen J; Groth S; Lange P; Hermansen F
Thorax; 1991 Nov; 46(11):817-23. PubMed ID: 1771605
[TBL] [Abstract][Full Text] [Related]
38. Hypertrophic effect of inhaled beta
Jessen S; Onslev J; Lemminger A; Backer V; Bangsbo J; Hostrup M
Scand J Med Sci Sports; 2018 Oct; 28(10):2114-2122. PubMed ID: 29777633
[TBL] [Abstract][Full Text] [Related]
39. Chronic β
Hostrup M; Onslev J; Jacobson GA; Wilson R; Bangsbo J
J Physiol; 2018 Jan; 596(2):231-252. PubMed ID: 28983994
[TBL] [Abstract][Full Text] [Related]
40. Urine concentrations of vilanterol and its metabolites, GSK932009 and GW630200, after inhalation of therapeutic and supratherapeutic doses.
Østergaard M; Jessen S; Hansen ESH; Backer V; Panchal T; Baldwin S; Daley-Yates P; Hostrup M
Drug Test Anal; 2023 May; 15(5):516-528. PubMed ID: 36610030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
